This inventor holds 14 USPTO granted patents, plus 4 CIPO patents. Top assignees: Merrell Dow Pharmaceuticals, Richardson-Merrell Inc.. Active years: 1976-1991.
Company Filing History:
Years Active: 1976-1991
Title: The Innovations of George P. Claxton
Introduction
George P. Claxton is a notable inventor based in Cincinnati, OH, with a remarkable portfolio of 14 patents. His work primarily focuses on the development of novel compounds that have significant implications in the medical field, particularly in treating hypertension and asthma.
Latest Patents
Among his latest patents are the "Process for preparing quinoline aldehyde and ketone derivatives" and the "Method of using quinolyloxazole-2-ones as protein kinase C inhibitors." These inventions relate to quinolyloxazole-2-ones, which serve as effective protein kinase C inhibitors. The innovative procedures he developed involve the reaction of a bromo-quinoline compound with butyl lithium, followed by further reactions with N-methyl-N-methoxyalkanamide to produce intermediate ketone compounds.
Career Highlights
Claxton has had a distinguished career, contributing to significant advancements in pharmaceutical chemistry. He has worked with reputable companies such as Merrell Dow Pharmaceuticals and Richardson-Merrell Inc., where he applied his expertise to develop groundbreaking medical solutions.
Collaborations
Throughout his career, Claxton has collaborated with esteemed colleagues, including Winton D. Jones and J. Martin Grisar, enhancing the innovative capacity of his projects.
Conclusion
George P. Claxton's contributions to the field of pharmaceutical chemistry through his patents and collaborations have made a lasting impact on medical treatments. His innovative spirit continues to inspire advancements in healthcare.